Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bicycle Therapeutics Ltd (BCYC)
NASDAQ:BCYC
RESEARCH TOOLSreports
Holding BCYC?
Track your performance easily
See the Price Targets and Ratings of:
BCYC Analyst Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BCYC Stock 12 Month Forecast
Average Price Target
$39.10
▲(56.65% Upside)
| Highest Price Target$56.00 | Average Price Target$39.10 | Lowest Price Target$25.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stephens
Initiated
11/07/24
Morgan Stanley
Reiterated
11/05/24
H.C. Wainwright
Reiterated
11/01/24
Barclays
Reiterated
11/01/24
JMP Securities
Reiterated
11/01/24
RBC Capital
Assigned
10/31/24
TD Cowen
Reiterated
10/31/24
Needham
Reiterated
10/31/24
Leerink Partners
Reiterated
10/31/24
Oppenheimer
Reiterated
10/24/24
Jefferies
$56
Buy
124.36%
Upside
Reiterated
09/19/24
Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (NASDAQ: BCYC) and Radnet (NASDAQ: RDNT)
B.Riley Financial
$28
Hold
12.18%
Upside
Downgraded
08/06/24
Bicycle Therapeutics: Hold Rating Amid Clinical and Competitive Challenges
Cantor Fitzgerald
―
Buy
―
Reiterated
06/03/24
Cantor Fitzgerald reiterates Overweight Rating on Bicycle Therapeutics (BCYC)Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Bicycle Therapeutics (NASDAQ: BCYC).
Canaccord Genuity
$60
Buy
140.38%
Upside
Reiterated
02/20/24
Bicycle Therapeutics: A Strong Buy on Promising Trials and Financial Stability
Best Analysts Covering Bicycle Therapeutics
Which Analyst Should I Follow If I Want to Buy BCYC and Sell After:
1 Month
xxx
Success Rate
10/20 ratings generated profit
Average Return
+1.65%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.65% per trade.
3 Months
xxx
Success Rate
13/20 ratings generated profit
Average Return
+10.09%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 65.00% of your transactions generating a profit, with an average return of +10.09% per trade.
1 Year
2 Years
xxx
Success Rate
15/20 ratings generated profit
Average Return
+6.68%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +6.68% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BCYC Analyst Recommendation Trends
Rating
Jun 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
6
8
12
17
15
Buy
5
7
7
11
9
Hold
0
2
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
17
21
30
26
Each month's total comprises the sum of three months' worth of ratings.
BCYC Financial Forecast
BCYC Stock Forecast FAQ
What is BCYC’s average 12-month price target, according to analysts?
Based on analyst ratings, Bicycle Therapeutics Ltd’s 12-month average price target is $39.10.
What is BCYC’s upside potential, based on the analysts’ average price target?
Bicycle Therapeutics Ltd has 56.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BCYC a Buy, Sell or Hold?
Bicycle Therapeutics Ltd has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
What is Bicycle Therapeutics Ltd’s price target?
The average price target for Bicycle Therapeutics Ltd is $39.10. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $56.00 ,the lowest forecast is $25.00. The average price target represents 56.65% Increase from the current price of $24.96.
The highest analyst price target is $56.00 ,the lowest forecast is $25.00. The average price target represents 56.65% Increase from the current price of $24.96.
What do analysts say about Bicycle Therapeutics Ltd?
Bicycle Therapeutics Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of BCYC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.